PCMSX
Price
$15.78
Change
-$0.29 (-1.80%)
Updated
Feb 21 closing price
Net Assets
2.53B
VMVAX
Price
$85.40
Change
-$0.97 (-1.12%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

PCMSX vs VMVAX

Header iconPCMSX vs VMVAX Comparison
Open Charts PCMSX vs VMVAXBanner chart's image
Principal MidCap Value I R6
Price$15.78
Change-$0.29 (-1.80%)
VolumeN/A
Net Assets2.53B
Vanguard Mid-Cap Value Index Admiral
Price$85.40
Change-$0.97 (-1.12%)
VolumeN/A
Net Assets30.89B
PCMSX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCMSX vs. VMVAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCMSX is a Hold and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. PCMSX (2.53B). VMVAX pays higher dividends than PCMSX: VMVAX (2.14) vs PCMSX (1.24). PCMSX was incepted earlier than VMVAX: PCMSX (6 years) vs VMVAX (13 years). PCMSX is a more actively managed with annual turnover of: 49.90 vs. VMVAX (22.00). PCMSX has a lower initial minimum investment than VMVAX: PCMSX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 12.44 vs. PCMSX (-5.31). VMVAX return over 5 years is better than : 38.46 vs. PCMSX (16.62).
PCMSXVMVAXPCMSX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years13 years-
Gain YTD1.2841.92167%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.53B30.9B8%
Annual Yield % from dividends1.242.1458%
Returns for 1 year-5.3112.44-43%
Returns for 3 years-2.9415.34-19%
Returns for 5 years16.6238.4643%
Returns for 10 yearsN/A81.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDI9.96-0.02
-0.20%
DoubleDown Interactive Co Ltd
MANU14.46-0.15
-1.03%
Manchester United PLC
SRPT106.28-2.13
-1.96%
Sarepta Therapeutics
FTK8.22-0.20
-2.38%
Flotek Industries
ARTL1.16-0.04
-3.33%
Artelo Biosciences